We would like to inform you that this page is being merged into the BBI Solutions company page. Moving forward, all updates, news, and insights will be shared there. We encourage you to follow BBI Solutions to stay informed. Thank you for your continued support
关于我们
BBI Solutions has acquired Maine Biotechnology Services to become a premier provider of antibody services offering: *Recombinant Antigen Development, *Hybridoma Development (Including Anti-Idiotypic projects) *Antibody Production and Purification Services *Preliminary Assay Development *Polyclonal Antibody Services BBI brings over 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved, we have risen to the challenge to effectively meet those needs. The cornerstone of antibody and assay development at BBI is our technical team approach to project design and planning. The BBI antibody development plan focuses on the timely generation of data from large fusion screens that allow for the identification of quality antibody candidates. A rigorous set of innovative and thorough screening tools are creatively developed and executed to meet dynamic customer goals with data-driven decision making. If the goals of a project change during the course of development, BBI will use accumulated data to efficiently shift focus to meet the new goals. Our mission is to use these strategies to go beyond limited contract services and be a comprehensive partner in antibody and assay method development. BBI saves customers money and compresses timelines of the most complex projects. BBI is more than smart hands. Discuss your antibody requirements with our technical team or browse our services to learn more. Contact us today for more information at info@bbisolutions.com
- 网站
-
http://www.bbisolutions.com
BBI Solutions - Maine (Formerly Maine Biotechnology Services)的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- Portland,ME
- 类型
- 私人持股
- 创立
- 1990
- 领域
- Antibody Discovery、Hybridoma development、Antibody production and purification、Antibody catalog、Recombinant Antigen Production、Assay Development Services、Octet Red、Anti-Idiotypic Antibody Specialists和Antibody In Vitro Production
地点
-
主要
1037 Forest Ave
US,ME,Portland,04103